glp 1 gip gcg receptor agonist Glucagon - an overview Glucagon-like peptide-1 receptor co-agonists for

Additionally, the greater reductions in body weight, HbA1c, and FPG with combination therapy versus monotherapies further underscore its potential to optimize glycemic control and weight management, which are cornerstones of comprehensive diabetes care

Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality and renal outcomes in patients with diabetes and albuminuria: a systematic review and meta-analysis

doi: 10.1210/clinem/dgab722

Fluorescent ligand-based strategies have emerged as powerful solutions

Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein

Future research should focus on elucidating the complex mechanisms underlying their psychological effects and integrating mental health considerations into therapeutic strategies